ViroMed
Pioneering gene therapy for neurological and cardiovascular diseases.
Seoul, South Korea · Founded 1996
- Headquarters
- Seoul
- Employees
- 51–200
- Founded
- 1996
- Business Model
- B2B
- Website
- viromed.co.kr
About
ViroMed is a South Korean biotechnology company specializing in gene therapy products, founded in 1996 by Sunyoung Kim. The company is best known for VM202, a plasmid DNA-based gene medicine targeting painful diabetic peripheral neuropathy (PDPN), amyotrophic lateral sclerosis (ALS), diabetic foot ulcer, and myocardial infarction. ViroMed's disease platform approach allows multiple indications to be addressed using shared technology, enabling cost-effective and rapid R&D across neurological and cardiovascular diseases.
Summary
ViroMed is a Biotech company based in Seoul, South Korea, founded in 1996.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/viromed"><img src="https://indexed.vc/api/badge/company/viromed" alt="ViroMed on Indexed.vc" width="260" height="76" /></a>